Title | Promotion of hepatocarcinogenesis by perfluoroalkyl acids in rainbow trout. |
Publication Type | Journal Article |
Year of Publication | 2012 |
Authors | Benninghoff, AD, Orner, GA, Buchner, CH, Hendricks, JD, Duffy, AM, Williams, DE |
Journal | Toxicol Sci |
Volume | 125 |
Issue | 1 |
Pagination | 69-78 |
Date Published | 2012 Jan |
ISSN | 1096-0929 |
Keywords | Aflatoxin B1, Alkanesulfonic Acids, Animals, Caprylates, Carcinogenicity Tests, Cocarcinogenesis, Decanoic Acids, Endocrine Disruptors, Fluorocarbons, Gene Expression, Gene Expression Profiling, Hydrocarbons, Fluorinated, Liver Neoplasms, Experimental, Methylnitronitrosoguanidine, Oligonucleotide Array Sequence Analysis, Oncorhynchus mykiss, Real-Time Polymerase Chain Reaction |
Abstract | Previously, we reported that perfluorooctanoic acid (PFOA) promotes liver cancer in a manner similar to that of 17β-estradiol (E2) in rainbow trout. Also, other perfluoroalkyl acids (PFAAs) are weakly estrogenic in trout and bind the trout liver estrogen receptor. The primary objective of this study was to determine whether multiple PFAAs enhance hepatic tumorigenesis in trout, an animal model that represents human insensitivity to peroxisome proliferation. A two-stage chemical carcinogenesis model was employed in trout to evaluate PFOA, perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDA), perfluorooctane sulfonate (PFOS), and 8:2 fluorotelomer alcohol (8:2FtOH) as complete carcinogens or promoters of aflatoxin B(1) (AFB(1))- and/or N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced liver cancer. A custom trout DNA microarray was used to assess hepatic transcriptional response to these dietary treatments in comparison with E2 and the classic peroxisome proliferator, clofibrate (CLOF). Incidence, multiplicity, and size of liver tumors in trout fed diets containing E2, PFOA, PFNA, and PFDA were significantly higher compared with AFB(1)-initiated animals fed control diet, whereas PFOS caused a minor increase in liver tumor incidence. E2 and PFOA also enhanced MNNG-initiated hepatocarcinogenesis. Pearson correlation analyses, unsupervised hierarchical clustering, and principal components analyses showed that the hepatic gene expression profiles for E2 and PFOA, PFNA, PFDA, and PFOS were overall highly similar, though distinct patterns of gene expression were evident for each treatment, particularly for PFNA. Overall, these data suggest that multiple PFAAs can promote liver cancer and that the mechanism of promotion may be similar to that of E2. |
DOI | 10.1093/toxsci/kfr267 |
Alternate Journal | Toxicol. Sci. |
PubMed ID | 21984479 |
PubMed Central ID | PMC3243748 |
Grant List | P30 ES00210 / ES / NIEHS NIH HHS / United States P30 ES03850 / ES / NIEHS NIH HHS / United States R01 ES013534 / ES / NIEHS NIH HHS / United States T32 ES07060 / ES / NIEHS NIH HHS / United States P42 ES016465 / ES / NIEHS NIH HHS / United States |